Released May 11, 2017, during market hours
10-Q filed May 11, 2017, 41 days after period end · 0000926617-17-000036
Q1 2017 · 10-Q
Revenue$726.00K$726.00K +43.8% vs Q1 2016−9.8% vs Q4 2016
Net Income-$2.67M-$2.67M N/M vs Q1 2016N/M vs Q4 2016
EPS Diluted-$0.05-$0.05 N/M vs Q1 2016no prior Q4 2016 on file
Gross Profit-$1,000N/M
Operating Income-$2,656,000N/M
Operating Cash Flow-$2,421,000N/M
Free Cash Flowderived-$2,447,000N/M
Margins · derived
Gross margin-0.1%+4.4 pt vs Q1 2016
Operating margin-365.8%+603.7 pt vs Q1 2016
Net margin-368.2%+601.5 pt vs Q1 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $726.00K | $505.00K | $951.00K | $305.00K |
| Net Income | -$2.67M | -$4.90M | -$4.14M | -$3.99M |
| EPS Diluted | -$0.05 | -$0.09 | -$0.10 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR